Patents by Inventor Jill C. Mikulecky

Jill C. Mikulecky has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6387625
    Abstract: An electrode for detecting interactions between members of a binding pair, which electrode has been modified by formation of a non-conductive self-assembled monolayer, and a method of detecting biomolecules, such as nucleic acids or other targets, including receptors, ligands, antigens or antibodies, utilizing such an electrode. When contacted with a target nucleic acid, an oligonucleotide probe coupled to the self-assembled monolayer reacts with the target nucleic acid form a hybridized nucleic acid on the modified electrode surface. The hybridized nucleic acid is reacted with a transition metal complex capable of oxidizing a preselected base in the hybridized nucleic acid in an oxidation-reduction reaction, the oxidation-reduction reaction is detected, and the presence or absence of the nucleic acid is determined from the detected oxidation-reduction reaction.
    Type: Grant
    Filed: June 19, 2000
    Date of Patent: May 14, 2002
    Assignees: The University of North Carolina at Chapel Hill, Xanthon, Inc.
    Inventors: Allen E. Eckhardt, Jill C. Mikulecky, Mary E. Napier, Robert S. Thomas, H. Holden Thorp
  • Patent number: 6127127
    Abstract: An electrode for detecting interactions between members of a binding pair, which electrode has been modified by formation of a non-conductive self-assembled monolayer, and a method of detecting biomolecules, such as nucleic acids or other targets, including receptors, ligands, antigens or antibodies, utilizing such an electrode. When contacted with a target nucleic acid, an oligonucleotide probe coupled to the self-assembled monolayer reacts with the target nucleic acid to form a hybridized nucleic acid on the modified electrode surface. The hybridized nucleic acid is reacted with a transition metal complex capable of oxidizing a preselected base in the hybridized nucleic acid in an oxidation-reduction reaction, the oxidation-reduction reaction is detected, and the presence or absence of the nucleic acid is determined from the detected oxidation-reduction reaction.
    Type: Grant
    Filed: April 22, 1999
    Date of Patent: October 3, 2000
    Assignees: The University of North Carolina at Chapel Hill, Xanthon, Inc.
    Inventors: Allen E. Eckhardt, Jill C. Mikulecky, Mary E. Napier, Robert S. Thomas, H. Holden Thorp